#AartiDrugs #Q3Results

👍Net profit up 1.1% at ₹37.1 cr vs ₹36.7 cr (YoY)

👎Revenue down 8.1% at ₹556.6 cr vs ₹605.9 cr (YoY)

👎EBITDA down 11.8% at ₹61.8 cr vs ₹70.1 cr (YoY)

👎Margin at 11.1% vs 11.6% (YoY)

#Q3 #Q3FY25
#AartiDrugs #Q3Results #Q3 #Q3FY25